Recurrence in Early-Stage Breast Cancer with N1 without Postmastectomy Radiotherapy.Wen, Ge; Zhang, Jin-Shan; Zhang, Yu-Jing; Zhu, Yu-Jia; Huang, Xiao-Bo; Guan, Xun-Xing.J Breast Cancer; 19(2): 176-84, 2016 Jun.66.Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets.Grosset, Andree-Anne; Labrie, Marilyne; Vladoiu, Maria Claudia; Yousef, Einas M; Gaboury, Louis; St-Pierre, Yves.Oncotarget; 7(14): 18183-203, 2016 Apr 5.67.HER2/CEP17 Ratios and Clinical Outcome in HER2-Positive Early Breast Cancer Undergoing Trastuzumab-Containing Therapy.Stocker, Albina; Hilbers, Marie-Luise; Gauthier, Claire; Grogg, Josias; Kullak-Ublick, Gerd A; Seifert, Burkhardt; Varga, Zsuzsanna; Trojan, Andreas.PLoS One; 11(7): e0159176, 2016.68.The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures.Cockburn, Jessica G; Hallett, Robin M; Gillgrass, Amy E; Dias, Kay N; Whelan, T; Levine, M N; Hassell, John A; Bane, Anita.BMC Cancer; 16: 555, 2016.69.Value of Ki-67 expression in triple-negative breast cancer before and after neoadjuvant chemotherapy with weekly paclitaxel plus carboplatin.Wang, Ruo-Xi; Chen, Sheng; Jin, Xi; Shao, Zhi-Ming.Sci Rep; 6: 30091, 2016.70.Improved Risk Stratification for Breast Cancer Samples Based on the Expression Ratio of the Estrogen and Progesterone Receptor.Bendrat, Klaus; Fritz, Peter; Muller, Simon; Brockmoller, Sylvia; Debus, Annegret; Friedrichs, Kay; Lindner, Christoph;Brinkmann, Friedhelm; Heidemann, Else; Niendorf, Axel.Anticancer Res; 36(8): 3855-63, 2016 Aug.71.Immunotherapy in Breast Cancer.Marme, Frederik.Oncol Res Treat; 39(6): 335-45, 2016.72.Prognostic Factors for Breast Cancer: an Immunomorphological Update.Roncati, Luca; Barbolini, Giuseppe; Piacentini, Federico; Piscioli, Francesco; Pusiol, Teresa; Maiorana, Antonio.Pathol Oncol Res; 22(3): 449-52, 2016 Jul.73.Androgen receptor and metastasis-associated protein-1 are frequently expressed in estrogen receptor negative/HER2 positive breast cancer.Zhao, Lin; Niu, Fengting; Shen, Honghong; Liu, Xiaozhen; Chen, Lijuan; Niu, Yun.Virchows Arch; 468(6): 687-96, 2016 Jun.74.Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry.Wirtz, Ralph M; Sihto, Harri; Isola, Jorma; Heikkila, Paivi; Kellokumpu-Lehtinen, Pirkko-Liisa; Auvinen, Paivi;Turpeenniemi-Hujanen, Taina; Jyrkkio, Sirkku; Lakis, Sotiris; Schlombs, Kornelia; Laible, Mark; Weber, Stefan; Eidt, Sebastian; Sahin, Ugur; Joensuu, Heikki.Breast Cancer Res Treat; 157(3): 437-46, 2016 Jun.75.The staging value of sentinel lymph node biopsy for breast cancer: translating pathologic findings to clinical practice.Bao, Jean; Donovan, Cory; Chung, Alice; Giuliano, Armando E.Chin Clin Oncol; 5(3): 36, 2016 Jun.76.The West German Study Group Breast Cancer Intrinsic Subtype study: a prospective multicenter decision impact study utilizing the Prosigna assay for adjuvant treatment decision-making in estrogen-receptor-positive, HER2-negative early-stage breast cancer.Wuerstlein, R; Sotlar, K; Gluz, O; Otremba, B; von Schumann, R; Witzel, I; Schindlbeck, C; Janni, W; Schem, C;Bauerfeind, I; Hasmueller, S; Tesch, H; Paulenz, A; Ghali, N; Orujov, E; Kates, R E; Cowens, W; Hornberger, J; Pelz, E;Harbeck, N.Curr Med Res Opin; 32(7): 1217-24, 2016 Jul.77.Significance of prognostic indicators in infiltrating duct carcinoma breast: Scenario in developing country.Krishnamurthy, J; Kumar, P Sandeep.Indian J Cancer; 53(1): 34-8, 2016 Jan-Mar.78.Her2-neu score as a prognostic factor for outcome in patients with triple-negative breast cancer.Schmidt, Gilda; Gerlinger, Christoph; Juhasz-Boss, Ingolf; Stickeler, Elmar; Rody, Achim; Liedtke, Cornelia; Wimberger, Pauline; Link, Theresa; Muller, Eberhard; Fehm, Tanja; Abel, Manuela; Stein, Stefan; Bohle, Rainer; Endrikat, Jan;Solomayer, Erich-Franz.J Cancer Res Clin Oncol; 142(6): 1369-76, 2016 Jun.79.New Gene Profiling in Determination of Breast Cancer Recurrence and Prognosis in Iranian Women.Poorhosseini, Seyed Mohammad; Hashemi, Mohammad; Alipour Olyaei, Nasrin; Izadi,